¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå ¼ºÀå°ú µ¿Çâ
¼¼°è ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå ±Ô¸ð´Â 2030³â 157¾ï 1,000¸¸ ´Þ·¯·Î 2025-2030³â±îÁö ¿¬Æò±Õ 8.1% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¿þ¾î·¯ºí ÆÐÄ¡´Â ÇǺο¡ ºÙÀÌ°í ¸î ½Ã°£¿¡¼ ¸î ÁÖ µ¿¾È Âø¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃÖ±Ù ¸î ³â µ¿¾È ÀÌ·¯ÇÑ ÆÐÄ¡ÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ¾à¹°Àü´Þ, ȯÀÚ ¸ð´ÏÅ͸µ, ½ºÆ÷Ã÷ µî¿¡ °¡Àå ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´ÏÄÚÆ¾°ú °°Àº ¾à¹°Àü´Þ ¹× ´Ù¾çÇÑ ¸¸¼ºÁúȯÀÇ Ä¡·á¿¡µµ »ç¿ëµË´Ï´Ù. ´Ù¾çÇÑ ±â¾÷µéÀÌ °æÀï ¿ìÀ§¸¦ È®º¸Çϱâ À§ÇØ ÀÌ ±â¼ú¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.
Ä¿³ØÆ¼µå ¿þ¾î·¯ºí ÆÐÄ¡ ºÎ¹®Àº 2024³â °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¹«¼± ¿¬°á ±â´ÉÀ» °®Ãß°í ÀÖ¾î ȯÀÚÀÇ °Ç° »óŸ¦ ¸ð´ÏÅ͸µÇÏ°í ±×¿¡ µû¶ó ¾à¹°À» Åõ¿©ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀå ¿äÀÎÀº °Ç°¿¡ ´ëÇÑ »ç¶÷µéÀÇ °ü½É Áõ°¡¿Í ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖ´Â °í·ÉÈ Àα¸ÀÇ Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ´õ ¸¹Àº µ¥ÀÌÅÍ Á¤È®µµ¿Í ±â´ÉÀ» °®Ãá Ä¿³ØÆ¼µå ¿þ¾î·¯ºí ÆÐÄ¡¸¦ ÃËÁøÇÏ´Â ±â¼ú °³¹ßÀº ÇâÈÄ ½ÃÀå¿¡ »õ·Î¿î Áøº¸Àû ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿ëµµº°·Î´Â ÀÓ»ó ºÎ¹®ÀÌ ¿¹»ó ±â°£ µ¿¾È °¡Àå ³ôÀº Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â Á¤±âÀûÀÎ Á¤º¸ ¼öÁý¿¡ µµ¿òÀÌ µÇ¸ç, ÀÌÈÄ ³ëÆ®ºÏÀ̳ª ½º¸¶Æ®Æù°ú °°Àº ¿¬°á ÀåÄ¡·Î µ¥ÀÌÅ͸¦ º¯È¯ÇÏ¿© Àǻ簡 ½Ç½Ã°£À¸·Î Áö¼ÓÀûÀÎ µ¥ÀÌÅÍ È帧¿¡ ¾×¼¼½ºÇÏ¿© ȯÀÚÀÇ ¾Çȸ¦ ¹æÁöÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.
ºÏ¹Ì´Â °í·ÉÈ Àα¸ Áõ°¡, ÀüÀÚÇǺΠ±â¼ú Çâ»ó, ¿¬±¸°³¹ß ÅõÀÚ Áõ°¡·Î 2024³â 36.0%·Î °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, º´¿ø°ú Çмú ±â°ü°úÀÇ Çù·Â °ü°è Áõ°¡, »ê¾÷ ¹× Çмú ¼öÁØÀÇ ¿¬±¸ °³¹ß Ȱµ¿ÀÇ È®»ê, »ý¹°ÀÇÇÐ ÀÀ¿ë ¹üÀ§ÀÇ È®´ë°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ª¿¡ ÁøÃâÇÑ ÁÖ¿ä ±â¾÷µéÀÇ ÁøÃâµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- Ä¿³ØÆ¼µå ¿þ¾î·¯ºí ºÎ¹®Àº 2024³â ½ÅÈï±¹ ½ÃÀåÀÇ ÀüÀÚ ÇǺΠ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¾à 76.5%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù.
- ºñÀÓ»ó ºÎ¹®Àº 2024³â 57.0%ÀÇ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ÀÇ·á±â±â ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ÀÎÇØ ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.
- ºÏ¹Ì ½ÃÀåÀº 2024³â 36.0%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù. ÀÌ´Â È¿À²ÀûÀÎ ÀÇ·á ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ½º¸¶Æ® ÆÐÄ¡ÀÇ °³¹ßÀÌ ºü¸£°Ô ÁøÇàµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- »óºÎ ½ÃÀå Àü¸Á
- °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå ºÐ¼® Åø
- »ê¾÷ ºÐ¼® - Porter's Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå : À¯Çüº°, ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå : À¯Çü º¯µ¿ ºÐ¼®
- ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå À¯Çüº° Àü¸Á
- 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
- ¿Âµµ ÆÐÄ¡
- ±Û·çÄÚ½º ÆÐÄ¡
- ½É¹Ú¼ö¿Í ECG ÆÐÄ¡
- ±âŸ
Á¦5Àå ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå : ±â¼úº°, ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå : ±â¼ú º¯µ¿ ºÐ¼®
- ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå ±â¼úº° Àü¸Á
- 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
- ·¹±Ö·¯ ¿þ¾î·¯ºí
- Ä¿³ØÆ¼µå ¿þ¾î·¯ºí
Á¦6Àå ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå : ¿ëµµ º¯µ¿ ºÐ¼®
- ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå ¿ëµµº° Àü¸Á
- 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
- ÀÓ»ó
- ºñÀÓ»ó
Á¦7Àå ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
- ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå ÃÖÁ¾ ¿ëµµº° Àü¸Á
- 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
- º´¿ø
- ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
- ÀçÅÃÀÇ·á
Á¦8Àå ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®
- Áö¿ª ´ë½Ãº¸µå
- ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå : Áö¿ª º¯µ¿ ºÐ¼®
- ¿þ¾î·¯ºí ÆÐÄ¡ ½ÃÀå : ±â¼ú°ú ÃÖÁ¾ ¿ëµµ¿¡ ÀÇÇÑ Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
- 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
- ºÏ¹Ì
- ¹Ì±¹
- ij³ª´Ù
- ¸ß½ÃÄÚ
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ÀϺ»
- Áß±¹
- Àεµ
- Çѱ¹
- È£ÁÖ
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- Äí¿þÀÌÆ®
Á¦9Àå °æÀï ±¸µµ
- ½ÃÀå ÁøÃâ ±â¾÷ ºÐ·ù
- ÁÖ¿ä ±â¾÷ °³¿ä
- AliveCor, Inc
- VivaLNK, Inc
- Cardiac Insight Inc
- VitalConnect
- LifeSignals, Inc
- L'Oreal Group
- Dexcom, Inc
- GENTAG, Inc
- Abbott Laboratories
- Koninklijke Philips NV
- Sensium Healthcare Ltd
- Leaf Healthcare, Inc
- Qualcomm Technologies, Inc
ksm 25.01.03
Wearable Patch Market Growth & Trends:
The global wearable patch market size is valued at USD 15.71 billion in 2030 and is projected to grow at a CAGR of 8.1% from 2025 to 2030. Wearable Patch is attached to the skin and can be worn for a couple of hours to weeks. In recent years these patches have become more popular and are most widely used for drug delivery or patient monitoring, and sports. They are also used to deliver medication such as nicotine and to treat various chronic diseases. Various companies are investing in this technology to gain a competitive advantage.
The connected wearable patch segment accounted for the highest market share in 2024. It has wireless connectivity features that help in monitoring the health of patients and delivering drugs accordingly. The factors responsible for the growth of the segment are growing concern among people related to their health and the increasing aging population with chronic diseases. Also, technological developments to boost the connected wearable patch with more data accuracy and features are anticipated to bring new advanced opportunities for the market in the coming future.
Based on the application, the clinical segment shares the highest market during the estimated period. It helps to gather information on a regular basis and then transforms data to connected devices such as laptops and smartphones so that the physicians have access to a real-time, continuous flow of data, which can avert patient worsening.
North America held the highest revenue share of 36.0% in 2024 due to its rising aging population, technological improvement in electronic skin, and increasing investment in R&D. In addition, increasing collaborations between hospitals, academic institutions, and widespread R&D activities at the industrial and academic level and increase in the scope of biomedical applications, have fueled the market growth. Moreover, the presence of major players in the region contributed to market growth.
Wearable Patch Market Report Highlights:
- The connected wearable segment dominated the market in 2024 and accounted for a revenue share of around 76.5% owing to increasing demand for electronic skin in developing countries
- The non-clinical segment accounted for the largest market share of 57.0% in 2024 is anticipated to maintain its dominance due to increasing investment in R&D of the medical device
- North America dominated the market and accounted for a revenue share of 36.0% in 2024. This can be attributed to the rapid increase in the development of smart patches to meet the growing demand for efficient healthcare in the country
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Technology
- 1.2.3. Application
- 1.2.4. End use
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Technology outlook
- 2.2.3. Application outlook
- 2.2.4. End Use outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Wearable Patch Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing prevalence of chronic diseases
- 3.2.1.2. Increasing technological advancements in wearable patch
- 3.2.1.3. Rising awareness among consumers regarding wearable patch
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of sensor patch
- 3.3. Wearable Patch Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
Chapter 4. Wearable Patch Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Wearable Patch Market: Type Movement Analysis
- 4.3. Wearable Patch Market by Type Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Temperature Patch
- 4.5.1. Temperature Patch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Glucose Patch
- 4.6.1. Glucose Patch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Heart Rate and ECG Patch
- 4.7.1. Heart Rate and ECG Patch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8. Others
- 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Wearable Patch Market: Technology Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Wearable Patch Market: Technology Movement Analysis
- 5.3. Wearable Patch Market by Technology Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Regular Wearable
- 5.5.1. Regular Wearable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Connected Wearable
- 5.6.1. Connected Wearable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Wearable Patch Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Wearable Patch Market: Application Movement Analysis
- 6.3. Wearable Patch Market by Application Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. Clinical
- 6.5.1. Clinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Non-clinical
- 6.6.1. Non-clinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Wearable Patch Market: End use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Wearable Patch Market: End use Movement Analysis
- 7.3. Wearable Patch Market by End use Outlook (USD Million)
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5. Hospitals
- 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Ambulatory Surgical Centers
- 7.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Homecare Settings
- 7.7.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Wearable Patch Market: Regional Estimates & Trend Analysis
- 8.1. Regional Dashboard
- 8.2. Regional Wearable Patch Market movement analysis
- 8.3. Wearable Patch Market: Regional Estimates & Trend Analysis by Technology & End use
- 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 8.5. North America
- 8.5.1. North America Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. U.S.
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Reimbursement scenario
- 8.5.2.5. U.S. Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Canada
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Reimbursement scenario
- 8.5.3.5. Canada Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. Mexico
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Scenario
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. Reimbursement scenario
- 8.5.4.5. Mexico Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Europe
- 8.5.6. Europe Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. UK
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Competitive Scenario
- 8.5.7.3. Regulatory Framework
- 8.5.7.4. Reimbursement scenario
- 8.5.7.5. UK Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.8. Germany
- 8.5.8.1. Key Country Dynamics
- 8.5.8.2. Competitive Scenario
- 8.5.8.3. Regulatory Framework
- 8.5.8.4. Reimbursement scenario
- 8.5.8.5. Germany Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.9. France
- 8.5.9.1. Key Country Dynamics
- 8.5.9.2. Competitive Scenario
- 8.5.9.3. Regulatory Framework
- 8.5.9.4. Reimbursement scenario
- 8.5.9.5. France Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.10. Italy
- 8.5.10.1. Key Country Dynamics
- 8.5.10.2. Competitive Scenario
- 8.5.10.3. Regulatory Framework
- 8.5.10.4. Reimbursement scenario
- 8.5.10.5. Italy Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.11. Spain
- 8.5.11.1. Key Country Dynamics
- 8.5.11.2. Competitive Scenario
- 8.5.11.3. Regulatory Framework
- 8.5.11.4. Reimbursement scenario
- 8.5.11.5. Spain Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.12. Denmark
- 8.5.12.1. Key Country Dynamics
- 8.5.12.2. Competitive Scenario
- 8.5.12.3. Regulatory Framework
- 8.5.12.4. Reimbursement scenario
- 8.5.12.5. Denmark Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.13. Sweden
- 8.5.13.1. Key Country Dynamics
- 8.5.13.2. Competitive Scenario
- 8.5.13.3. Regulatory Framework
- 8.5.13.4. Reimbursement scenario
- 8.5.13.5. Sweden Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.14. Norway
- 8.5.14.1. Key Country Dynamics
- 8.5.14.2. Competitive Scenario
- 8.5.14.3. Regulatory Framework
- 8.5.14.4. Reimbursement scenario
- 8.5.14.5. Norway Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Asia Pacific
- 8.6.1. Asia Pacific Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Japan
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Reimbursement scenario
- 8.6.2.5. Japan Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. China
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Reimbursement scenario
- 8.6.3.5. China Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. India
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. Reimbursement scenario
- 8.6.4.5. India Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. South Korea
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Reimbursement scenario
- 8.6.5.5. South Korea Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.6. Australia
- 8.6.6.1. Key Country Dynamics
- 8.6.6.2. Competitive Scenario
- 8.6.6.3. Regulatory Framework
- 8.6.6.4. Reimbursement scenario
- 8.6.6.5. Australia Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.7. Thailand
- 8.6.7.1. Key Country Dynamics
- 8.6.7.2. Competitive Scenario
- 8.6.7.3. Regulatory Framework
- 8.6.7.4. Reimbursement scenario
- 8.6.7.5. Thailand Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7. Latin America
- 8.7.1. Latin America Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.2. Brazil
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory Framework
- 8.7.2.4. Reimbursement scenario
- 8.7.2.5. Brazil Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Argentina
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory Framework
- 8.7.3.4. Reimbursement scenario
- 8.7.3.5. Argentina Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8. Middle East & Africa
- 8.8.1. Middle East & Africa Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.2. South Africa
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Competitive Scenario
- 8.8.2.3. Regulatory Framework
- 8.8.2.4. Reimbursement scenario
- 8.8.2.5. South Africa Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.3. Saudi Arabia
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Competitive Scenario
- 8.8.3.3. Regulatory Framework
- 8.8.3.4. Reimbursement scenario
- 8.8.3.5. Saudi Arabia Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.4. UAE
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. Competitive Scenario
- 8.8.4.3. Regulatory Framework
- 8.8.4.4. Reimbursement scenario
- 8.8.4.5. UAE Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.5. Kuwait
- 8.8.5.1. Key Country Dynamics
- 8.8.5.2. Competitive Scenario
- 8.8.5.3. Regulatory Framework
- 8.8.5.4. Reimbursement scenario
- 8.8.5.5. Kuwait Wearable Patch Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Key Company Profiles
- 9.2.1. AliveCor, Inc
- 9.2.1.1. Company overview
- 9.2.1.2. Financial performance
- 9.2.1.3. Product benchmarking
- 9.2.1.4. Strategic initiatives
- 9.2.2. VivaLNK, Inc
- 9.2.2.1. Company overview
- 9.2.2.2. Financial performance
- 9.2.2.3. Product benchmarking
- 9.2.2.4. Strategic initiatives
- 9.2.3. Cardiac Insight Inc
- 9.2.3.1. Company overview
- 9.2.3.2. Financial performance
- 9.2.3.3. Product benchmarking
- 9.2.3.4. Strategic initiatives
- 9.2.4. VitalConnect
- 9.2.4.1. Company overview
- 9.2.4.2. Financial performance
- 9.2.4.3. Product benchmarking
- 9.2.4.4. Strategic initiatives
- 9.2.5. LifeSignals, Inc
- 9.2.5.1. Company overview
- 9.2.5.2. Financial performance
- 9.2.5.3. Product benchmarking
- 9.2.5.4. Strategic initiatives
- 9.2.6. L'Oreal Group
- 9.2.6.1. Company overview
- 9.2.6.2. Financial performance
- 9.2.6.3. Product benchmarking
- 9.2.6.4. Strategic initiatives
- 9.2.7. Dexcom, Inc
- 9.2.7.1. Company overview
- 9.2.7.2. Financial performance
- 9.2.7.3. Product benchmarking
- 9.2.7.4. Strategic initiatives
- 9.2.8. GENTAG, Inc
- 9.2.8.1. Company overview
- 9.2.8.2. Financial performance
- 9.2.8.3. Product benchmarking
- 9.2.8.4. Strategic initiatives
- 9.2.9. Abbott Laboratories
- 9.2.9.1. Company overview
- 9.2.9.2. Financial performance
- 9.2.9.3. Product benchmarking
- 9.2.9.4. Strategic initiatives
- 9.2.10. Koninklijke Philips N.V.
- 9.2.10.1. Company overview
- 9.2.10.2. Financial performance
- 9.2.10.3. Product benchmarking
- 9.2.10.4. Strategic initiatives
- 9.2.11. Sensium Healthcare Ltd
- 9.2.11.1. Company overview
- 9.2.11.2. Financial performance
- 9.2.11.3. Product benchmarking
- 9.2.11.4. Strategic initiatives
- 9.2.12. Leaf Healthcare, Inc
- 9.2.12.1. Company overview
- 9.2.12.2. Financial performance
- 9.2.12.3. Product benchmarking
- 9.2.12.4. Strategic initiatives
- 9.2.13. Qualcomm Technologies, Inc
- 9.2.13.1. Company overview
- 9.2.13.2. Financial performance
- 9.2.13.3. Product benchmarking
- 9.2.13.4. Strategic initiatives